Divi’s Laboratories on Monday said its consolidated net profit increased by 78 per cent to Rs 895 crore in the quarter ended on March 31, 2022.

The drug maker had reported a net profit of Rs 502 crore in the January-March quarter of 2020-21 fiscal.

Revenue from operations rose to Rs 2,518 crore for the fourth quarter ended on March 31, 2022, as against Rs 1,788 crore in the year-ago period, Divi’s Laboratories said in a regulatory filing.

For the year ended in March 2022, the company posted a consolidated net profit of Rs 2,960 crore as against Rs 1,984 crore in FY21.

Revenue from operations rose to Rs 8,960 crore as compared with Rs 6,969 crore in 2020-21.

The company said its board has recommended a dividend of Rs 30 per share of face value Rs 2 (1,500 per cent) for 2021-22, subject to approval of members at the ensuing annual general meeting.

Shares of the company were trading 6.37 per cent down at Rs 4,032.35 apiece on the BSE. PTI MSS MR MR

To stay updated with the Latest Stock Market news, download our app here!

For editorial purposes, contact news@tradebrains.in

Start Your Stock Market Journey Today!

Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!